Another explanation could be the low number of UA patients included in the study would not allow the Cuzick’s test to detect a significant trend in Gal1 levels along the follow-up.
← all excerpts
Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis.
1
—
—